NEW ALLIANCE BIOSCIENCES
New Alliance BioSciences is a development stage company, engages in the development and commercialization of perfluorocarbon based therapeutic oxygen carriers for use in the medical profession in the United States. The company primarily offers PHER-O2, a perflurcarbon emulsion under pre-clinical and clinical testing, which consists of perfluoro-decalin molecules, purified water, and a proprietary surfactant to hold the emulsion together. Its PHER-O2 has applications in various medical indication... s, including transportation of pancreas islets for treatment of diabetes; ophthalmic retinal surgery; angioplasty; external oxygenation of infection, ischemic tissue, and diabetic ulcers; Alzheimer's disease; traumatic brain injury; oxygenation of cancerous tumors; nuclear magnetic resonance imaging; CAT scans; cardioplegia or the priming of heart-lung machines in open heart surgery; and treatment of heart attacks, strokes, head and neck tumors, and hemorrhagic shock.
NEW ALLIANCE BIOSCIENCES
Industry:
Clinical Trials Medical Therapeutics
Founded:
1974-01-01
Address:
Roswell, Georgia, United States
Country:
United States
Status:
Active
Contact:
678-352-9060
Similar Organizations
Caerus Discovery
Caerus Discovery is a development stage company
Central Wireless
Central Wireless is a development stage company.
Enzerna
Enzerna Biosciences is a pre-clinical stage company.
Northern Shield Resources
Northern Shield Resources is a development-stage company.
Rindex Medical
Rindex Medical is a developmental-stage company.
Current Employees Featured